Rutgers Cancer Institute of New Jersey: Exploring PD-L1 Expression in Malignant Peritoneal Mesothelioma
March 20, 2021
March 20, 2021
NEW BRUNSWICK, New Jersey, March 20 (TNSRes) -- Rutgers Cancer Institute of New Jersey issued the following Q&A:
Peritoneal mesothelioma is a cancer that develops in the lining of the abdomen, which is known as the peritoneum. In a recent study from Rutgers Cancer Institute of New Jersey, researchers tested whether or not mesothelioma cancer cells express high amounts of PD-L1, a protein that is abundantly present on some types of cancer cells. The PD-L1 protein is an inhibitory . . .
Peritoneal mesothelioma is a cancer that develops in the lining of the abdomen, which is known as the peritoneum. In a recent study from Rutgers Cancer Institute of New Jersey, researchers tested whether or not mesothelioma cancer cells express high amounts of PD-L1, a protein that is abundantly present on some types of cancer cells. The PD-L1 protein is an inhibitory . . .